Skip to main content
. 2021 Dec 18;107(5):1441–1460. doi: 10.1210/clinem/dgab888

Figure 1.

Figure 1.

Risk factors for antiresorptive agent-related osteonecrosis of the jaw. AFF, atypical femoral fracture; BMA, bone-modifying agents; MM, multiple myeloma; ONJ, osteonecrosis of the jaw; VEGF, vascular endothelial growth factor.